<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:identifier>http://www.wikidata.org/entity/Q41488645</dc:identifier>
  <dc:identifier>doi:10.1007/S00104-016-0200-7</dc:identifier>
  <dc:title>Robot-assisted minimally invasive esophagectomy</dc:title>
  <dc:creator>Hillegersberg, R</dc:creator>
  <dc:creator>Seesing, F J</dc:creator>
  <dc:creator>Brenkman, Hylke J F</dc:creator>
  <dc:creator>Ruurda, J P</dc:creator>
  <dc:type>journal article</dc:type>
  <dc:date>2017-01-01</dc:date>
  <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
  <dc:publisher>Springer Science and Business Media LLC</dc:publisher>
  <dc:description>Esophagolymphadenectomy is the cornerstone of multimodality treatment for resectable esophageal cancer. The preferred surgical approach is transthoracic, with a two-field lymph node dissection and gastric conduit reconstruction. A minimally invasive approach has been shown to reduce postoperative complications and increase quality of life. Robot-assisted minimally invasive esophagectomy (RAMIE) was developed to facilitate this complex thoracoscopic procedure. RAMIE has been shown to be safe with good oncologic results and reduced morbidity. The use of RAMIE opens new indications for curative surgery in patients with T4b tumors, high mediastinal tumors, and lymph node metastases after neoadjuvant treatment.</dc:description>
</oai_dc:dc>